1,2-Dibromoethane

1,2-Dibromoethane

SCHEMBL198422

BrCCBr.COC.OCCO.[Ni]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.39
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,2-Dibromoethane SCHEMBL4449264 0.96 TSHR (0.41) TSHRHSD17B10TDP1
2-Bromoethanol SCHEMBL1472070 0.85
Ethylene Glycol SCHEMBL22007 0.80
Ethylene Glycol SCHEMBL8080969 0.80 TSHR (0.56) TSHR
Ethylene Glycol SCHEMBL9616343 0.80 TSHR (0.56) TSHR
Ethylene Glycol SCHEMBL6570599 0.80 TSHR (0.56) TSHR
Ethylene Glycol SCHEMBL15995529 0.80 TSHR (0.56) TSHR
Ethylene Glycol SCHEMBL8082558 0.80 TSHR (0.56) TSHR
Ethylene Glycol SCHEMBL27449247 0.76
Ethylene Glycol SCHEMBL27305226 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118307590-A Synthesis method of chiral alpha-alkenyl-beta-alkyl phosphate 南京工业大学 2024-07-09 CN claimed
CN-118307589-A Synthesis method of achiral alpha-alkenyl-beta-alkyl phosphate 南京工业大学 2024-07-09 CN claimed
CN-116178312-B Synthesis method of chiral cyclic ether 武汉大学 2024-06-25 CN claimed
CN-116063209-B Method for preparing benzylamine derivative by catalyzing amination of benzyl C-H bond through nickel under promotion of visible light 上海沃凯生物技术有限公司 2024-04-09 CN claimed
CN-117659080-A Synthesis method of chiral alpha-aryl-beta-alkyl phosphate 南京工业大学 2024-03-08 CN claimed
CN-115417859-B Synthesis method of rizatriptan benzoate 陕西师范大学 2024-02-02 CN claimed
CN-117486740-A Novel method for efficiently synthesizing chiral alpha-amino acid derivative by asymmetric reduction addition reaction of transition metal catalytic imine 华东理工大学 2024-02-02 CN claimed
CN-117362271-A Method for preparing nicotine 湖北和诺生物工程股份有限公司 2024-01-09 CN claimed
CN-114907197-B Preparation method of biaziridine-based photocrosslinking probe intermediate and derivative 中国人民解放军海军军医大学 2024-01-02 CN claimed
CN-114874081-B Preparation method of green efficient alpha-functionalized ketone 中国人民解放军海军军医大学 2023-12-22 CN claimed
US-20220119331-A1 Processes for the Preparation of Zuclomiphene Intermediates THE BANK OF NOVA SCOTIA (CA) 2022-04-21 US claimed
CN-114292300-A Spiro-dihydrobenzothiolline phosphonite monoester compound, preparation and application thereof 中国科学院上海有机化学研究所 2022-04-08 CN claimed
US-11046638-B2 Processes for the preparation of zuclomiphene and intermediates thereof APOTEX INC. (CA) 2021-06-29 US claimed
CN-112939750-A Method for transferring asymmetric functionalization by nickel-hydrogen catalysis olefin promoted by ligand relay strategy 南京大学 2021-06-11 CN claimed
US-20210147337-A1 Processes for the Preparation of Zuclomiphene and Intermediates Thereof THE BANK OF NOVA SCOTIA (CA) 2021-05-20 US claimed
CN-111254457-B Electrochemical synthesis method of aromatic carboxylic acid and alkyl carboxylic acid 四川大学 2021-05-11 CN claimed
CN-112679290-A Nickel-catalyzed asymmetric hydrogen alkynylation method for olefins and application of nickel-catalyzed asymmetric hydrogen alkynylation method in preparation of AMG837 南京大学 2021-04-20 CN claimed
CN-111254457-A Electrochemical synthesis method of aromatic carboxylic acid and alkyl carboxylic acid 四川大学 2020-06-09 CN claimed
CN-110878012-A Synthetic method of E-type methyl styrene compound 南京大学 2020-03-13 CN claimed
WO-2007140525-A1 A METHOD OF TREATMENT AND PROPHYLAXIS OF EVENTS, CONDITIONS AND DISEASES OF THE SYSTEMIC VASCULATURE AN IMMUNE FUNCTION TO DECREASE CARDIOVASCULAR RISK AND PATHOGENIC INFECTION HOENIG MICHEL (AU) 2007-12-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11046638-B2 Processes for the preparation of zuclomiphene and intermediates thereof CYP3A43, UGT1A3, ZDHHC7 TSHR 4282/4885HSD17B10 219/4885TDP1 4368/4885
US-20210147337-A1 Processes for the Preparation of Zuclomiphene and Intermediates Thereof CYP3A43, UGT1A3, ZDHHC7 TSHR 4282/4885HSD17B10 219/4885TDP1 4368/4885
US-20220119331-A1 Processes for the Preparation of Zuclomiphene Intermediates CYP4F2, CYP4F12, CYP1A2 TSHR 3878/4885HSD17B10 184/4885TDP1 4738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.